Ignite Creation Date:
2024-05-06 @ 6:56 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05834231
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-04-28
First Post:
2023-04-17
Brief Title:
Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity
Sponsor:
Mansoura University
Organization:
Mansoura University
Study Overview
Official Title:
Efficacy of Memantine in Prevention of Oxaliplatin-induced Peripheral Neurotoxicity
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Memantine is a drug for the management of Alzheimers Disease AD due to its promising neuroprotective properties We hypothesize that Memantine possesses a beneficial role against chemotherapy-induced neuronal damages
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None